Wells Fargo initiated coverage on Bio-Techne with a new price target

5/30/25 8:40:12 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Wells Fargo initiated coverage of Bio-Techne with a rating of Overweight and set a new price target of $59.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TECH

Date	Price Target	Rating	Analyst
5/30/2025	$59.00	Overweight	Wells Fargo
4/9/2025		Overweight → Sector Weight	KeyBanc Capital Markets
3/18/2025	$75.00	Outperform	Evercore ISI
2/19/2025	$88.00 → $68.00	Outperform → Neutral	Robert W. Baird
5/22/2024	$85.00	Buy → Neutral	Citigroup
2/8/2024	$80.00	Sector Outperform	Scotiabank
2/2/2024	$65.00	Buy → Hold	Stifel
12/7/2023	$80.00	Buy	UBS